MedPath
HSA Approval

VANCOMYCIN POWDER FOR SOLUTION FOR INJECTION/INFUSION 500mg

SIN14527P

VANCOMYCIN POWDER FOR SOLUTION FOR INJECTION/INFUSION 500mg

VANCOMYCIN POWDER FOR SOLUTION FOR INJECTION/INFUSION 500mg

March 14, 2014

MYLAN PHARMACEUTICALS PTE. LTD.

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01XA01

vancomycin

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited [Specialty Formulation Facility]

Active Ingredients

VANCOMYCIN HYDROCHLORIDE 512.571 mg/vial EQV VANCOMYCIN

500 mg/vial

Vancomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VANCOMYCIN POWDER FOR SOLUTION FOR INJECTION/INFUSION 500mg - HSA Approval | MedPath